Rhythm Pharmaceuticals Stock
Rhythm Pharmaceuticals Stock
Heavy losses for Rhythm Pharmaceuticals today as the stock fell by -€1.400 (-4.000%).
With 15 Buy predictions and not the single Sell prediction the community is currently very high on Rhythm Pharmaceuticals.
As a result the target price of 45 € shows a positive potential of 30.06% compared to the current price of 34.6 € for Rhythm Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Rhythm Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.
Pros and Cons of Rhythm Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhythm Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals | -4.000% | -6.989% | -5.464% | 124.675% | -18.779% | - | - |
| Ardelyx Inc. | -2.930% | -3.853% | 15.454% | 108.097% | 19.170% | 20.842% | - |
| Evolus Inc | -5.830% | 2.564% | 13.208% | 34.078% | 32.597% | 61.074% | - |
| Salarius Pharmaceuticals Inc. | 5.580% | 3.141% | -10.860% | -67.167% | -29.009% | -98.470% | -99.993% |
Comments
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target lowered by analysts at Needham & Company LLC from $50.00 to $46.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $50.00 price target on the stock.
Show more
Ratings data for RYTM provided by MarketBeat